Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 213 Myelodysplastic Syndromes 82 Leukemia 44 Leukemia, Myelomonocytic, Chronic 35 Recurrence 16 Myeloproliferative Disorders 15 Neoplasm, Residual 10 Lymphoma, T-Cell, Peripheral 10 Leukemia, Biphenotypic, Acute 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Myelodysplastic-Myeloproliferative Diseases 7 Lymphoma, Large B-Cell, Diffuse 7 Anemia, Refractory, with Excess of Blasts 7 Primary Myelofibrosis 6 Lymphoma, Non-Hodgkin 6 Hodgkin Disease 6 Congenital Abnormalities 6 Lymphoma, T-Cell 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Leukemia, Monocytic, Acute 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Hematologic Neoplasms 5 Polycythemia Vera 4 Pancreatic Neoplasms 4 Multiple Myeloma 4 Lymphoma, Follicular 4 Lymphoma, Extranodal NK-T-Cell 4 Leukemia, Myeloid 4

Interventions

Temozolomide 109 Magnetic Resonance Spectroscopy 52 Bevacizumab 52 Radiotherapy 44 Irinotecan 27 Blood Specimen Collection 19 Surgical Procedures, Operative 16 Radiation 15 Aminolevulinic Acid 15 Carboplatin 13 fluorodopa F 18 12 Nivolumab 12 Radiotherapy, Intensity-Modulated 11 Carmustine 11 Radiosurgery 10 Magnetic Resonance Imaging 10 pembrolizumab 9 Topotecan 9 Specimen Handling 9 Everolimus 9 Erlotinib Hydrochloride 9 Biopsy 9 poly ICLC 8 Surveys and Questionnaires 8 Standard of Care 8 Etoposide 8 Drug Therapy 8 Lomustine 7 Filgrastim 7 Cyclophosphamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioma × Azacitidine × Clear all

NCT03666559 2024-02-29

AGIR

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡